Skip to search formSkip to main contentSkip to account menu

Fenoldopam

Known as: Fenoldopam [Chemical/Ingredient], Fenoldopamum, 1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)- 
A benzazepine derivative with vasodilatory and antihypertensive properties. Fenoldopam, a dopamine (DA) receptor agonist, binds specifically to… 
National Institutes of Health

Related topics

Related topics

23 relations
1 ML Fenoldopam 10 MG/ML Injection [Corlopam]Congestive heart failureDecreased Blood Pressure [PE]Fenoldopam Mesylate

Broader (5)

Antihypertensive AgentsBenzazepinesDiureticsDopamine Agonists

Narrower (3)

CorlopamSK&F-82526SKF-82526J

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Fenoldopam Preconditioning: Role of Heme Oxygenase-1 in Protecting Human Tubular Cells and Rodent Kidneys Against Cold-Hypoxic Injury
Background. Kidneys from brain-dead donors are cold preserved until transplanted. However, prolonged cold storage can contribute… 
2009
2009
Defining contrast-induced nephropathy.
Contrast-induced nephropathy (CIN) is one of the most common forms of hospital-acquired acute kidney injury (1). The elective or… 
2008
2008
Institutional report - Congenital Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial
We determined if low dose fenoldopam in neonates already receiving conventional diuretics improves urine output, fluid balance… 
2007
2007
Diagnosis and treatment of hypertensive crises in the elderly patients
Hypertension is a common clinical problem in the elderly worldwide and physicians of all types are likely to encounter patients… 
2001
2001
Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series.
Many of the longstanding challenges in interventional cardiology, such as restenosis and thrombosis, have been met. However… 
2000
2000
Regulation of NHE 3 activity by G protein subunits in renal brush-border membranes
FREDERICK E. ALBRECHT,1,2 JING XU,1 ORSON W. MOE,3 ULRICH HOPFER,4 WILLIAM F. SIMONDS,5 JOHN ORLOWSKI,6 AND PEDRO A. JOSE1,2… 
1993
1993
Intravenous fenoldopam infusion in severe heart failure
SummaryFenoldopam, a selective DA1-receptor agonist, infused intravenously for 24 hours (0.6 ± 0.3 µg/kg/min, range 0.1–1.5) in… 
1987
1987
Selective renal dopamine-1 receptor stimulation in man.
The selective dopamine-1 (DA-1) receptor agonist, fenoldopam, was studied during intravenous administration to ten normal male… 
1986
1986
The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
This study was designed to investigate dopaminergic mechanisms in human vasculature using the selective vascular dopamine… 
1984
1984
Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.
Summary: Until recently, the key pharmacologic tools necessary for major advances in understanding and studying cardiovascular…